HIGHLIGHTS
- who: Junfeng Duan from the State Key Laboratory of Pharmaceutical Biotechnology Department of Cardiology, Medical School of Nanjing University, Nanjing Drum Tower Hospital, No, Zhongshan Road, Nanjing, China have published the research: Trophoblast Stem-Cell-Derived Exosomes Alleviate Cardiotoxicity of Doxorubicin via Improving Mfn2-Mediated Mitochondrial Fusion, in the Journal: (JOURNAL)
- what: The study explored the influence of TSC-Exos on the mitochondrial dynamics of Dox-induced cardiotoxicity. This study showed mitochondrial fission could be aggravated by Dox through the downregulation of Mfn2 expression in cardiomyocytes. The findings of this study have to be seen . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.